Ten patient-reported questions assessing the ability to perform daily functional tasks. The simple average of all ten responses gives the BASFI score on a 0-10 scale. Validated against physical measurements and correlates with long-term work disability in axial SpA.
| BASFI | Functional Status | Clinical Meaning |
|---|---|---|
| 0 to 2 | Good Function | Minimal functional limitation. Consistent with low disease activity. |
| 2 to 4 | Mild Limitation | Some functional restriction. Monitor for progression. |
| 4 to 6 | Moderate Limitation | Meaningful functional impairment. Associated with increased work disability risk. |
| > 6 | Severe Limitation | Significant disability. Review disease control and consider physiotherapy referral. |
BASFI MCID: approximately 0.7 points. A change of this magnitude is considered clinically meaningful in the context of therapeutic intervention.
BASFI was developed by Calin, Garrett, and colleagues and published in the Journal of Rheumatology in 1994. The 10-item questionnaire was designed to assess function specifically relevant to axial spondyloarthritis. Validation demonstrated strong correlation with clinical measures and radiographic progression, and BASFI has been incorporated into the Bath indices as the standard functional outcome for AS/axial SpA.